In the present work, we investigated the molecular mechanisms of CKS2 in endometrial carcinoma via diverse methods of genetic mutation profile analysis, upstream transcriptional analysis, immune correlation analysis, and co-expression analysis. Here, CKS2 is linked to endometrial carcinoma.